Saturday, November 21, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Penny Stocks

The Final Chapter for Novan: Shares Cease Trading as Liquidation Concludes

Kennethcix by Kennethcix
February 12, 2026
in Penny Stocks, Pharma & Biotech, Turnaround
0
Novan Stock
0
SHARES
92
VIEWS
Share on FacebookShare on Twitter

Investors holding shares of Novan have reached the end of the line. The company’s stock is now effectively worthless, a direct result of its 2023 bankruptcy proceedings and the subsequent sale of its core business operations. Recent trading data from early February confirms a complete absence of volume, indicating the delisting process is final.

A Bankruptcy with No Recovery for Shareholders

The decisive event occurred in July 2023 when Novan filed for Chapter 11 creditor protection. As part of that process, the company sold substantially all of its assets to Ligand Pharmaceuticals. This move stripped the publicly traded entity of any fundamental business foundation, transferring its entire operational capacity to the buyer.

Should investors sell immediately? Or is it worth buying Novan?

For remaining equity holders, the implications are stark. The established hierarchy in such bankruptcy cases is clear: secured creditors and other claimants are prioritized for any remaining value. Common shareholders typically stand last in line and receive nothing, a scenario strongly supported by the recent trading halt and the apparent total loss for investors.

Key Points for Former Investors

  • Operational Wind-Down: The company’s business activities were either terminated or fully transferred during 2023.
  • Ticker Inactivity: The listing under the symbol NOVN now shows zero trading activity.
  • Bankruptcy Status: The insolvency proceedings are in their final phase.

The company’s former research pipeline, including the development of berdazimer gel for molluscum contagiosum, continues under the stewardship of Ligand Pharmaceuticals. However, this provides no residual value to the original Novan corporate shell. The liquidation of this remaining entity is proceeding and will conclude without any distribution to its former shareholders, cementing the total loss for those who held the stock.

Ad

Novan Stock: Buy or Sell?! New Novan Analysis from November 21 delivers the answer:

The latest Novan figures speak for themselves: Urgent action needed for Novan investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 21.

Novan: Buy or sell? Read more here...

Tags: Novan
Kennethcix

Kennethcix

Related Posts

Novo Nordisk Stock
Analysis

Novo Nordisk Faces a New Front: 300-Fold Rise in GLP-1 Scripts for Children Under 12

September 7, 2026
DroneShield Stock
Analysis

DroneShield’s European Ambitions Face Off Against an Unresolved ASIC Probe

September 7, 2026
Novo Nordisk Stock
European Markets

Novo Nordisk’s Two-Front Battle: US Price Concessions Meet a Pipeline Fighting for Credibility

September 6, 2026
Next Post
D-Wave Quantum Stock

D-Wave Quantum Receives Bullish Initiation from TD Cowen

Lynas Stock

Lynas Shares Gain Momentum Amid Favorable Market and Policy Shifts

Barrick Stock

Barrick's Planned Spinoff Faces Legal Challenge from Joint Venture Partner

Recommended

WM stock news

Spire Wealth Management Shows Confidence in Churchill Downs Incorporated with New Acquisition and Bet on Future Growth

3 years ago
Chevron Stock

Chevron Shares Surge Amid Global Oil Supply Disruption

8 months ago
Q2 Holdings Stock

Inclusion in S&P SmallCap 600 Index Ignites Q2 Holdings Stock Rally

1 year ago
REV Stock

REV Group Shares Hit Record High Amid Political Scrutiny

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

Rotation, Not Panic: Retailers Test Where Tech’s Money Went

At 5.15%, the 10-Year Treasury Picks the Winners

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

Huang Exits, Cisco Reports: Who Actually Gets Paid for AI

Trending

CrowdStrike Stock
Newsletter

93% of Stocks Fall as CrowdStrike Courts Zscaler

by Stephanie Dugan
November 21, 2026
0

Dear readers, The question heading into Friday was whether Anthropic would hold its $83 offer price. It...

Nvidia Stock

Anthropic Lists at a Premium, but the Sell-Off Keeps Going

November 20, 2026
Bitcoin Stock

Anthropic’s $81 Billion IPO Meets a Market in Need of Good News

November 19, 2026
Nvidia Stock

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

November 18, 2026
Home Depot Stock

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

November 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • 93% of Stocks Fall as CrowdStrike Courts Zscaler
  • Anthropic Lists at a Premium, but the Sell-Off Keeps Going
  • Anthropic’s $81 Billion IPO Meets a Market in Need of Good News

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com